gpms_logo
  • Company
    • Management
    • Company
    • Locations
    • Mission / Values
    • Contact
  • Major Clients
  • References
  • News/Events
  • Career
  • English
    • Deutsch
    • English

Serum plant Dresden

Project Description

The GSK saxon Serum plant produces flu vaccination substances for the world market, with a yearly production of aprox. 30 million of doses. 94.3 million € was the investment amount destinated to built the plant. For the flu campaigne 2008/2009 GSK will be able to duplicate its production.

Data
Our performance
Data
Project type: Pharmaceutical production plant for vaccines
Location: Germany (Dresden)
Investment amount: 94.3 Mio. EUR
Investor: GlaxoSmithKline GmbH & Co.KG
Time period: 01.05.2006 – 30.04.2007
Performance: Time scheduling, planning and control of resources
Our performance

Time scheduling of structure work, building and process technics as well as scheduling and control of resources during the planning and execution time.

More reference projects

Sunways Arnstadt

Sunways Arnstadt

RDC Infineon

RDC Infineon

Alpha-Schott Jena

Alpha-Schott Jena

ErSol Solar Erfurt

ErSol Solar Erfurt

Intel Israel Procurement

Intel Israel Procurement

Intel Israel Procurement
Intel Israel Procurement
Siltronic Fab 300-1
Siltronic Fab 300-1

References

Sunways Arnstadt

Sunways Arnstadt

RDC Infineon

RDC Infineon

Alpha-Schott Jena

Alpha-Schott Jena

ErSol Solar Erfurt

ErSol Solar Erfurt

Intel Israel Procurement

Intel Israel Procurement

Serum plant Dresden

Serum plant Dresden

GPMS GmbH

Gesellschaft für Projektmanagement

Denkendorfer Straße 11
D-70771 Leinfelden-Echterdingen

Telefon: +49 711 722 488-11
Telefax: +49 711 722 488-13
E-Mail: info@gpms.biz

Search:

© gpms.biz